1. PsatyBM, O'DonnellCJ, GudnasonV, LunettaKL, FolsomAR, et al. (2009) Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet 2: 73–80.
2. GermanJB, HammockBD, WatkinsSM (2005) Metabolomics: building on a century of biochemistry to guide human health. Metabolomics 1: 3–9.
3. SuhreK, GiegerC (2012) Genetic variation in metabolic phenotypes: study designs and applications. Nat Rev Genet 13: 759–769.
4. TeslovichTM, MusunuruK, SmithAV, EdmondsonAC, StylianouIM, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707–713.
5. SurakkaI, WhitfieldJB, PerolaM, VisscherPM, MontgomeryGW, et al. (2012) A genome-wide association study of monozygotic twin-pairs suggests a locus related to variability of serum high-density lipoprotein cholesterol. Twin Res Hum Genet 15: 691–699.
6. DupuisJ, LangenbergC, ProkopenkoI, SaxenaR, SoranzoN, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105–116.
7. KottgenA, AlbrechtE, TeumerA, VitartV, KrumsiekJ, et al. (2013) Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 45: 145–154.
8. GiegerC, GeistlingerL, AltmaierE, Hrabe de AngelisM, KronenbergF, et al. (2008) Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 4: e1000282.
9. SuhreK, WallaschofskiH, RafflerJ, FriedrichN, HaringR, et al. (2011) A genome-wide association study of metabolic traits in human urine. Nat Genet 43: 565–569.
10. SuhreK, ShinSY, PetersenAK, MohneyRP, MeredithD, et al. (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature 477: 54–60.
11. KettunenJ, TukiainenT, SarinAP, Ortega-AlonsoA, TikkanenE, et al. (2012) Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 44: 269–276.
12. FrazerKA, BallingerDG, CoxDR, HindsDA, StuveLL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851–861.
13. CampbellMC, TishkoffSA (2008) African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet 9: 403–433.
14. ManolioTA, CollinsFS, CoxNJ, GoldsteinDB, HindorffLA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461: 747–753.
15. GoAS, MozaffarianD, RogerVL, BenjaminEJ, BerryJD, et al. (2013) Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation 127: e6–e245.
16. Tarver-CarrME, PoweNR, EberhardtMS, LaVeistTA, KingtonRS, et al. (2002) Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol 13: 2363–2370.
17. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
18. XieW, WoodAR, LyssenkoV, WeedonMN, KnowlesJW, et al. (2013) Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes. Diabetes 62: 2141–2150.
19. Veiga-da-CunhaM, TytecaD, StroobantV, CourtoyPJ, OpperdoesFR, et al. (2010) Molecular identification of NAT8 as the enzyme that acetylates cysteine S-conjugates to mercapturic acids. J Biol Chem 285: 18888–18898.
20. ZhengY, YuB, AlexanderD, ManolioTA, AguilarD, et al. (2013) Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC Study. Am J Epidemiol 178: 534–542.
21. KottgenA, PattaroC, BogerCA, FuchsbergerC, OldenM, et al. (2010) New loci associated with kidney function and chronic kidney disease. Nat Genet 42: 376–384.
22. HindorffLA, SethupathyP, JunkinsHA, RamosEM, MehtaJP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362–9367.
23. ParkJH, GailMH, WeinbergCR, CarrollRJ, ChungCC, et al. (2011) Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. Proc Natl Acad Sci U S A 108: 18026–18031.
24. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661–678.
25. SamaniNJ, ErdmannJ, HallAS, HengstenbergC, ManginoM, et al. (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357: 443–453.
26. ErdmannJ, GrosshennigA, BraundPS, KonigIR, HengstenbergC, et al. (2009) New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 41: 280–282.
27. IlligT, GiegerC, ZhaiG, Romisch-MarglW, Wang-SattlerR, et al. (2010) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42: 137–141.
28. OzakiK, FujiwaraT, NakamuraY, TakahashiE (1998) Isolation and mapping of a novel human kidney- and liver-specific gene homologous to the bacterial acetyltransferases. J Hum Genet 43: 255–258.
29. ChambersJC, ZhangW, LordGM, van der HarstP, LawlorDA, et al. (2010) Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 42: 373–375.
30. TinA, ColantuoniE, BoerwinkleE, KottgenA, FranceschiniN, et al. (2013) Using multiple measures for quantitative trait association analyses: application to estimated glomerular filtration rate. J Hum Genet 58: 461–6.
31. JainNK, RoyI (2009) Effect of trehalose on protein structure. Protein Sci 18: 24–36.
32. TanakaM, MachidaY, NiuS, IkedaT, JanaNR, et al. (2004) Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat Med 10: 148–154.
33. DaviesJE, SarkarS, RubinszteinDC (2006) Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. Hum Mol Genet 15: 23–31.
34. RichardsAB, KrakowkaS, DexterLB, SchmidH, WolterbeekAP, et al. (2002) Trehalose: a review of properties, history of use and human tolerance, and results of multiple safety studies. Food Chem Toxicol 40: 871–898.
35. WuC, KraftP, ZhaiK, ChangJ, WangZ, et al. (2012) Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet 44: 1090–1097.
36. YouYJ, KimY, NamNH, BangSC, AhnBZ (2004) Alkyl and carboxylalkyl esters of 4′-demethyl-4-deoxypodophyllotoxin: synthesis, cytotoxic, and antitumor activity. Eur J Med Chem 39: 189–193.
37. CasigliaE, SpolaoreP, GinocchioG, AmbrosioGB (1993) Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol 9: 293–297.
38. KrumsiekJ, SuhreK, EvansAM, MitchellMW, MohneyRP, et al. (2012) Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information. PLoS Genet 8: e1003005.
39. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 129: 687–702.
40. OhtaT, MasutomiN, TsutsuiN, SakairiT, MitchellM, et al. (2009) Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol Pathol 37: 521–535.
41. EvansAM, DeHavenCD, BarrettT, MitchellM, MilgramE (2009) Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 81: 6656–6667.
42. GrambschPM, TherneauTM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81: 515–526.
43. LeveyAS, StevensLA, SchmidCH, ZhangYL, CastroAF3rd, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604–612.